Bioavailability Testing of Medicinal Products and Harmonization of International Testing Requirements and Standards: The Canadian Perspective

Abstract

Keywords

Bioavailability Bioequivalence Canadian standards Harmonization Acceptance criteria

Get full access to this article

View all access options for this article.

References

Report on bioavailability of oral dosage formulations of drugs used for systemic effects. A. Drugs with uncomplicated characteristics. Health and Welfare Canada, Health Protection Branch; August 1990.

Report on bioavailability of oral dosage formulations of drugs used for systemic effects. B. Modified release dosage forms. Health and Welfare Canada, Health Protection Branch; August 1990.

Schuirmann

. A comparison of the two onesided tests procedure and the power approach for assessing the equivalence of average bioavailability. J. Pharmacokinet. Biopharm. 1987;15: 657.

Skelly

Report of the workshop on controlled-release dosage forms: Issues and controversies. Pharm. Res. 1987;4: 75–77.

Skelly

Report of the workshop on in vitro and in vivo testing and correlation for oral controlled/modified release dosage forms. J. Pharm. Sci. 1990;79: 849–854.